RNXT

RenovoRx, Inc. Common Stock

1.70

USD

+0.03

+1.80%

Sep 22, 15:59 UTC -4

Closed

Pre-Market

1.70

0.00

-0.06%

RenovoRx, Inc. Common Stock Profile

About

RenovoRx Inc. is a biopharmaceutical company. It developed a therapy platform targeting difficult-to-treat tumors. RenovoRx Inc. is headquartered in Silicon Valley, California.

Info & Links

CEO

Shaun R. Bagai

Headquarters

2570 West El Camino Real, Suite 320
Mountain View, CA 94040, UNITED STATES

Auditor

Frank, Rimerman + Co. LLP

Share holders

128

Employees

RenovoRx, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

76.68M

Enterprise Value

67.20M

Enterprise Value/EBITDA(ttm)

-4.96

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

38.60

Price to Book(mrq)

8.48

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

84.41%

Operating Margin(ttm)

-576.82%

Profit Margin(ttm)

-819.02%

Return on Equity(ttm)

-135.11%

Return on Invested Capital(ttm)

-153.97%

Return on Assets(ttm)

-101.91%

Income Statement

Revenue(ttm)

1.98M

Revenue Per Share(ttm)

0.04

Gross Profit(ttm)

1.67M

EBITDA(ttm)³

-13.53M

Net Income Available to Common(ttm)

-12.29M

Diluted EPS(ttm)

-0.31

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

30.77%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

45.13M

Dividend Yield

0.00%

Float⁴

40.89M

% Held by Insiders

9.40%

% Held by Institutions

3.10%

Balance Sheet

Total Cash(mrq)

9.48M

Total Cash Per Share(mrq)

0.21

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.74%

Quick Ratio(mrq)

5.53%

Book Value Per Share(mrq)

0.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.14

Free Cash Flow(ytd)

-6.65M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.